MedTrace Logo

To Evaluate the Efficacy and Safety of TRD205 Tablets in the Treatment of Chronic Postoperative Neuralgia

NCT07123402 · Status: ENROLLING_BY_INVITATION · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2025-08-17

No results posted yet for this study

Summary

This is a phase II, multicenter ,randomized, double-blind, placebo-controlled, dose-finding study designed to evaluate the efficacy and safety of TRD205 tablets in the treatment of chronic postoperative neuralgia

Conditions

  • Chronic Postoperative Neuralgia

Interventions

DRUG

TRD205 tablets

orally ;Take TRD205 1 tablets and Placebo 2 tablets

DRUG

TRD205 tablets

orally ;Take TRD205 2 tablets and Placebo 1 tablets

DRUG

TRD205 tablets

orally ;Take TRD205 3 tablets and Placebo 0 tablets

DRUG

Placebo

orally ;Take Placebo 3 tablets

Sponsors & Collaborators

  • China-Japan Friendship Hospital

    collaborator OTHER

  • Beijing Tide Pharmaceutical Co., Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-09
Primary Completion
2026-04-20
Completion
2026-05-27

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07123402 on ClinicalTrials.gov